SLAC and Stanford scientists used it to zoom in on an iconic RNA catalyst and a piece of viral RNA that’s a potential target for COVID-19 treatments.

From the invisible world of elementary particles to the mysteries of the cosmos, recipients of this prestigious award for early career scientists explore nature at every level.

Derived from microscopic algae, the rare, light-driven enzyme converts fatty acids into starting ingredients for solvents and fuels.

Two groups of researchers drew on SLAC tools to better understand how to target a key part of the virus that causes COVID-19.

SSRL and LCLS scientists will help visiting research teams solve their experimental challenges, then apply what they’ve learned to help others work more efficiently.

G6PD deficiency affects about 400M people worldwide and can pose serious health risks. Uncovering the causes of the most severe cases could finally lead to treatments.

The study, done on a mild-mannered relative of the virus that causes COVID-19, paves the way for seeing more clearly how spike proteins initiate infections, with an eye to preventing and treating them.

The lab’s X-ray laser recently joined other facilities in making remote science possible from any corner of the world, a trend that will likely continue into the future.

Images reveal how some antibodies may block SARS-CoV-2 infection.

Scientists at the Stanford Synchrotron Radiation Lightsource will study plastics and biologically-motivated processes that break them down in hopes of finding more efficient ways to “upcycle” them.

No human cell can function without these tiny machines, which cause disease when they go haywire and offer potential targets for therapeutic drugs.

University of Alberta researchers worked with SLAC X-ray scientists to explore the potential of a feline coronavirus drug that may be effective against SARS-CoV-2.